Andrew R. Allen's most recent trade in Adaptimmune Therapeutics Plc - ADR was a trade of 660,000 Option to purchase Ordinary Shares done . Disclosure was reported to the exchange on July 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics P... | Andrew R. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 660,000 | 660,000 | - | - | Option to purchase Ordinary Shares | |
| Gritstone Bio Inc | Andrew R. Allen | Director, PRESIDENT AND CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jun 2024 | 325,000 | 985,360 (2%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Andrew R. Allen | Director, PRESIDENT AND CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jun 2024 | 325,000 | 1,124,275 (3%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Andrew R. Allen | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 615,000 | 615,000 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Andrew R. Allen | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 47,873 | 1,009,623 (2%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Andrew R. Allen | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 15 May 2024 | 24,263 | 985,360 (2%) | 0% | 0.7 | 18,156 | Common Stock |
| Gritstone Bio Inc | Allen R. Andrew | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 615,000 | 615,000 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Andrew R. Allen | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 105,000 | 899,345 (2%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Andrew R. Allen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 738,550 | 856,750 (2%) | 2% | 0 | Common Stock | |
| Gritstone Bio Inc | Andrew R. Allen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 410,000 | 410,000 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Andrew R. Allen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 70,000 | 118,200 (0%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Andrew R. Allen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 290,000 | 290,000 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Andrew R. Allen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 48,200 | 48,200 (0%) | 0% | 0 | Common Stock |